MedPath

LUXIQ

Luxíq (betamethasone valerate) Foam, 0.12%

Approved
Approval ID

3dab9411-df12-4073-9cc1-3273e2aee7e7

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jun 29, 2010

Manufacturers
FDA

Physicians Total Care, Inc.

DUNS: 194123980

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

betamethasone valerate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code54868-5424
Application NumberNDA020934
Product Classification
M
Marketing Category
C73594
G
Generic Name
betamethasone valerate
Product Specifications
Route of AdministrationTOPICAL
Effective DateMarch 29, 2011
FDA Product Classification

INGREDIENTS (9)

BETAMETHASONE VALERATEActive
Quantity: 1.2 mg in 1 g
Code: 9IFA5XM7R2
Classification: ACTIB
CETYL ALCOHOLInactive
Code: 936JST6JCN
Classification: IACT
CITRIC ACID MONOHYDRATEInactive
Code: 2968PHW8QP
Classification: IACT
ALCOHOLInactive
Code: 3K9958V90M
Classification: IACT
POLYSORBATE 60Inactive
Code: CAL22UVI4M
Classification: IACT
POTASSIUM CITRATEInactive
Code: EE90ONI6FF
Classification: IACT
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
STEARYL ALCOHOLInactive
Code: 2KR89I4H1Y
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

LUXIQ - FDA Drug Approval Details